Barriers to Treg therapy in Europe: From production to regulation
There has been an increased interest in cell based therapies for a range of medical conditions in the last decade. This explosion in novel therapeutics research has led to the development of legislation specifically focused on cell and gene based therapies. In Europe, the European medicines agency (...
Main Authors: | Hennessy, C, Deptula, M, Hester, J, Issa, F |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Frontiers Media
2023
|
Similar Items
-
Barriers to Treg therapy in Europe: From production to regulation
by: Conor Hennessy, et al.
Published: (2023-01-01) -
A GMP protocol for the manufacture of Tregs for clinical application
by: O'Neil, A, et al.
Published: (2022) -
Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use
by: Alzhrani, A, et al.
Published: (2020) -
Chimeric antigen receptors and regulatory T cells: the potential for HLA-specific immunosuppression in transplantation
by: Wright, S, et al.
Published: (2021) -
Translating Treg Therapy in Humanized Mice
by: Susanne Annette Hahn, et al.
Published: (2015-12-01)